作者
Anand Divakaran, Siva K Talluri, Alex M Ayoub, Neeraj K Mishra, Huarui Cui, John C Widen, Norbert Berndt, Jin-Yi Zhu, Angela S Carlson, Joseph J Topczewski, Ernst K Schonbrunn, Daniel A Harki, William CK Pomerantz
发表日期
2018/9/25
期刊
Journal of medicinal chemistry
卷号
61
期号
20
页码范围
9316-9334
出版商
American Chemical Society
简介
As regulators of transcription, epigenetic proteins that interpret post-translational modifications to N-terminal histone tails are essential for maintaining cellular homeostasis. When dysregulated, “reader” proteins become drivers of disease. In the case of bromodomains, which recognize N-ε-acetylated lysine, selective inhibition of individual bromodomain-and-extra-terminal (BET)-family bromodomains has proven challenging. We describe the >55-fold N-terminal-BET bromodomain selectivity of 1,4,5-trisubstituted-imidazole dual kinase–bromodomain inhibitors. Selectivity for the BRD4 N-terminal bromodomain (BRD4(1)) over its second bromodomain (BRD4(2)) arises from the displacement of ordered waters and the conformational flexibility of lysine-141 in BRD4(1). Cellular efficacy was demonstrated via reduction of c-Myc expression, inhibition of NF-κB signaling, and suppression of IL-8 production through …
引用总数
201920202021202220232024922171084
学术搜索中的文章